Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

New Technology Update

28 Nov 2018 07:00

RNS Number : 6896I
Plant Health Care PLC
28 November 2018
 

28 November 2018

 

PLANT HEALTH CARE plc

 

 

("Plant Health Care" or the "Company")

 

 

New Technology Update 

 

 

Plant Health Care®, a leading provider of novel patent-protected biological products to global agriculture markets, is pleased to provide the following update in relation to its New Technology business in corn and soy crops.

 

Highlights:

- Plant Health Care's novel PREtec (Plant Response Elicitor Technology) has very large potential in the more than 375 million acres of corn and soy planted in North America, Brazil and Argentina.

- Three more global agricultural/seed companies have signed agreements to evaluate Plant Health Care's PREtec product candidates on multiple crops on three continents.

- These new collaborators are seeking novel, low toxicity biological products such as PREtec, to enable farmers to be more productive with lower environmental impact.

- Plant Health Care is continuing field trials with the Company's Innatus 3G peptide PHC279 against Asian Soybean Rust (ASR) in Brazil.

 

PREtec is a novel, environmentally friendly approach to protecting crops, based on peptides derived from natural proteins. These proprietary peptides are stable and compatible with mainstream agriculture practices. By activating the innate growth and defence mechanisms of plants, PREtec peptides lead to higher crop yields and better protection against disease and environmental stresses such as drought.

 

Corn and soy are major targets for PREtec. They are grown on more than 375 million acres in North and South America. A yield increase of just 2% brings a soybean farmer in Brazil almost an additional $10 per acre; in the USA it brings a corn (maize) farmer almost $13 per acre. Plant Health Care's evaluation partners supply most of the leading corn and soy seed treatments.

 

PREtec peptides can also reduce the corn yield losses caused by drought stress during critical growth stages. Under the drought conditions of the Company's field trials, corn plants whose seeds were treated with PREtec increased yield by an average of almost 17% over three consecutive growing seasons compared to untreated plants.

 

Three additional global agricultural companies have now signed agreements to evaluate several platforms of the PREtec technology. These companies join existing evaluation partners, who are looking for novel technology that will boost yield in row crops and have a safe environmental profile while solving significant problems faced by growers today.

 

In the 2018/19 soybean growing season in Brazil, Plant Health Care will be conducting further trials of PHC279 against Asian Soybean Rust (ASR). Last season this product did not deliver a decisive impact on disease symptoms as a foliar spray, but did show yield improvements. This season, trials will assess the economic value of PHC279 seed treatment and early season sprays.

 

Chris Richards, Executive Chairman & Interim CEO, said "As we continue to generate positive results from our PREtec platform of peptides, we are delighted to expand our range of partners who will evaluate our technology on multiple crops in multiple regions during the 2019 growing season."

 

For further information, please contact:

 

Plant Health Care plc

 

Chris Richards, Executive Chairman and Interim CEO

 

Tel: +1 919 926 1600

Arden Partners plc (Nomad and Broker)

John Llewellyn-Lloyd

 

Dan Gee-Summons

Tel: +44 (0) 20 7614 5900

 

IFC Advisory (Financial PR)

 

Graham Herring

 

Miles Nolan

 

Zach Cohen

Tel: +44 (0) 20 3934 6630

 

 

 

Company website: www.planthealthcare.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDPGGCGGUPRGBM
Date   Source Headline
12th Nov 20193:56 pmRNSHolding(s) in Company
6th Nov 201912:57 pmRNSInvestment in Company by Ospraie Ag Science LLC
30th Oct 20197:00 amRNSAppointment of new Board Directors
3rd Oct 20192:50 pmRNSDirector/PDMR Shareholding
30th Sep 20197:00 amRNSInterim Report ended 30 June 2019
9th Sep 20197:00 amRNSPilot production of PREtec peptides
19th Aug 20197:00 amRNSBlock listing Interim Review
15th Aug 20197:00 amRNSProgress with PREtec field trials in Brazil
5th Aug 20195:18 pmRNSHolding(s) in Company
25th Jun 20197:00 amRNSNew Distribution Agreement with Wilbur-Ellis
12th Jun 201911:05 amRNSResult of AGM
30th Apr 20194:19 pmRNSAnnual Report & Accounts and AGM Notice Published
10th Apr 20197:00 amRNSResults for the year ended 31 December 2018
27th Mar 20193:41 pmRNSHolding(s) in Company
28th Feb 20197:00 amRNSNew Technology Update
19th Feb 20197:00 amRNSBlock listing Interim Review
29th Jan 20197:00 amRNSTrading Statement
24th Jan 20195:58 pmRNSHolding(s) in Company
21st Dec 20187:00 amRNSTrading Statement
28th Nov 20187:00 amRNSNew Technology Update
21st Nov 20187:00 amRNSPlant Health Care ProAct® Wins Top Industry Award
19th Nov 20187:00 amRNSPlant Health Care to present at Mello London
14th Nov 20187:00 amRNSPositive Developments with Harpin
8th Nov 20187:00 amRNSChange of Adviser
5th Nov 20187:00 amRNSHolding(s) in Company
18th Sep 20187:00 amRNSInterim Report ended 30 June 2018
12th Sep 20187:00 amRNSUS Announces Harpin aß Product Launch in Corn
20th Aug 20187:00 amRNSBlock listing Interim Review
30th Jul 20187:00 amRNSUpdate on sugarcane in Brazil
16th Jul 20187:00 amRNSTrading Statement
6th Jun 20182:39 pmRNSHolding(s) in Company
6th Jun 201811:14 amRNSResult of AGM
30th May 20187:00 amRNSGrant of Options
4th May 20185:59 pmRNSHolding(s) in Company
30th Apr 20183:11 pmRNSPublication of Annual Report and Notice of AGM
10th Apr 20187:00 amRNSResults for the year ended 31 December 2017
8th Mar 20187:00 amRNSBlock listing Interim Review
7th Mar 20183:07 pmRNSHolding(s) in Company
7th Mar 20183:06 pmRNSHolding(s) in Company
7th Mar 20183:02 pmRNSHolding(s) in Company
2nd Mar 20185:48 pmRNSHolding(s) in Company
27th Feb 20184:12 pmRNSResult of Placing and Subscription
27th Feb 20187:00 amRNSProposed Placing and Subscription
24th Jan 20187:00 amRNSTrading Statement
12th Dec 20177:00 amRNSNew Technology Update
8th Dec 20174:35 pmRNSPrice Monitoring Extension
6th Dec 20174:40 pmRNSSecond Price Monitoring Extn
6th Dec 20174:35 pmRNSPrice Monitoring Extension
18th Sep 20177:00 amRNSHalf-year Report
21st Aug 20177:00 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.